Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Sanders

Showing results (911-920 of 915) with videos related to

Pageof 92
Sort By:
You have reached the last page of results.This site can display upto 915 results.
Science Immunology|August 30, 2024
Germline-targeting HIV vaccination induces neutralizing antibodies to the CD4 binding siteTom G Caniels, Max Medina-Ramìrez, Shiyu Zhang, et al.
Blood Advances|February 3, 2022
Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patientsSabine Haggenburg, Birgit I Lissenberg-Witte, Rob S van Binnendijk, et al.
Science (New York, N.Y.)|September 23, 2021
Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium studyKathryn M Hastie, Haoyang Li, Daniel Bedinger, et al.
Science (New York, N.Y.)|May 15, 2025
Precise targeting of HIV broadly neutralizing antibody precursors in humansTom G Caniels, Madhu Prabhakaran, Gabriel Ozorowski, et al.
Blood Advances|February 24, 2026
Humoral and cellular immune response after COVID-19 vaccination in patients with sickle cell disease on hydroxyureaSabine Haggenburg, Cilia R Pothast, Quincy Hofsink, et al.
Pageof 92

Showing results (911-920 of 915) with videos related to

Sort By:
Pageof 92
You have reached the last page of results.This site can display upto 915 results.
Science Immunology|August 30, 2024
Germline-targeting HIV vaccination induces neutralizing antibodies to the CD4 binding siteTom G Caniels, Max Medina-Ramìrez, Shiyu Zhang, et al.
Blood Advances|February 3, 2022
Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patientsSabine Haggenburg, Birgit I Lissenberg-Witte, Rob S van Binnendijk, et al.
Science (New York, N.Y.)|September 23, 2021
Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium studyKathryn M Hastie, Haoyang Li, Daniel Bedinger, et al.
Science (New York, N.Y.)|May 15, 2025
Precise targeting of HIV broadly neutralizing antibody precursors in humansTom G Caniels, Madhu Prabhakaran, Gabriel Ozorowski, et al.
Blood Advances|February 24, 2026
Humoral and cellular immune response after COVID-19 vaccination in patients with sickle cell disease on hydroxyureaSabine Haggenburg, Cilia R Pothast, Quincy Hofsink, et al.
Pageof 92